Methotrexate and Adalimumab Decrease the Serum Levels of Cardiovascular Disease Biomarkers (VCAM-1 and E-Selectin) in Plaque Psoriasis

Methotrexate and Adalimumab Decrease the Serum Levels of Cardiovascular Disease Biomarkers (VCAM-1 and E-Selectin) in Plaque Psoriasis

<i>Background and objectives:</i> The shared pathogenesis of psoriasis and atherosclerosis may be determined by assaying the levels of endothelial activation molecules. This study aimed at evaluating vascular cell adhesion molecule 1 (VCAM-1) and E-selectin serum concentrations, and athe...

Full description

Bibliographic Details
Main Authors: Natalia Zdanowska, Agnieszka Owczarczyk-Saczonek, Joanna Czerwińska, Jacek J. Nowakowski, Anna Kozera-Żywczyk, Witold Owczarek, Wojciech Zdanowski, Waldemar Placek
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Medicina
Subjects:
VCAM-1
E-selectin
psoriasis
methotrexate
adalimumab
Online Access:https://www.mdpi.com/1010-660X/56/9/473

Internet

https://www.mdpi.com/1010-660X/56/9/473

Similar Items